Table 1 Participant Demographic Characteristics
From: Feasibility of three times weekly symptom screening in pediatric cancer patients
Characteristic | Total No. (%) | Cohort 1 | Cohort 2 |
|---|---|---|---|
Patient Characteristics | n = 30 | n = 20 | n = 10 |
Male | 19 (63.3%) | 14 (70.0%) | 5 (50.0%) |
Age in Years | |||
8–12 | 10 (33.3%) | 8 (40.0%) | 2 (20.0%) |
13–18 | 20 (66.7%) | 12 (60.0%) | 8 (80.0%) |
White | 17 (56.7%) | 9 (45.0%) | 8 (80.0%) |
Diagnosis | |||
Leukemia | 11 (36.7%) | 9 (45.0%) | 2 (20.0%) |
Lymphoma | 7 (23.3%) | 3 (15.0%) | 4 (40.0%) |
Solid tumor | 7 (23.3%) | 4 (20.0%) | 3 (30.0%) |
Brain tumor | 5 (16.7%) | 4 (20.0%) | 1 (10.0%) |
Metastatic Disease | 9 (30.0%) | 5 (25.0%) | 4 (40.0%) |
Relapse | 2 (6.7%) | 2 (10%) | 0 (0%) |
Treatments Received | |||
Chemotherapy | 29 (96.7%) | 19 (95.0%) | 10 (100.0%) |
Surgery | 1 (3.3%) | 0 (0.0%) | 1 (10.0%) |
Radiotherapy | 1 (3.3%) | 0 (0.0%) | 1 (10.0%) |
Stem cell transplantation | 2 (6.7%) | 2 (10%) | 0 (0%) |
Inpatient at Enrollment | 8 (26.7%) | 5 (25.0%) | 3 (30.0%) |
Date of Diagnosis | |||
< 6 months before enrollment | 20 (66.7%) | 10 (50%) | 10 (100%) |
6 to 12 months before enrollment | 5 (16.7%) | 5 (25%) | 0 (0%) |
> 12 months before enrollment | 5 (16.7%) | 5 (25.0%) | 0 (0%) |
English as First Language | 24 (80.0%) | 15 (75.0%) | 9 (90.0%) |
Other Languages Spoken | |||
French | 3 (10%) | 2 (10%) | 1 (10%) |
Tamil | 3 (10%) | 2 (10%) | 1 (10%) |
Other* | 8 (26.7%) | 7 (35%) | 1 (10%) |